Deutsche Bank’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,616
| Closed | -$94.9K | – | 3610 |
|
|
2024
Q1 | $94.9K | Sell |
1,616
-2,195
| -58% | -$94.6K | ﹤0.01% | 3193 |
|
|
2023
Q4 | $84.8K | Buy |
+3,811
| New | +$57.5K | ﹤0.01% | 3293 |
|
|
2023
Q3 | – | Sell |
-2,175
| Closed | -$147K | – | 3743 |
|
|
2023
Q2 | $147K | Sell |
2,175
-922
| -30% | -$381K | ﹤0.01% | 3060 |
|
|
2023
Q1 | $1.44M | Buy |
3,097
+368
| +13% | +$195K | ﹤0.01% | 1873 |
|
|
2022
Q4 | $1.09M | Buy |
2,729
+561
| +26% | +$215K | ﹤0.01% | 1999 |
|
|
2022
Q3 | $705K | Sell |
2,168
-2,192
| -50% | -$706K | ﹤0.01% | 2182 |
|
|
2022
Q2 | $1.15M | Buy |
4,360
+1,485
| +52% | +$379K | ﹤0.01% | 2083 |
|
|
2022
Q1 | $864K | Sell |
2,875
-96
| -3% | -$33.5K | ﹤0.01% | 2447 |
|
|
2021
Q4 | $1.05M | Buy |
2,971
+123
| +4% | +$38.3K | ﹤0.01% | 2410 |
|
|
2021
Q3 | $728K | Buy |
2,848
+305
| +12% | +$108K | ﹤0.01% | 2807 |
|
|
2021
Q2 | $1.69M | Sell |
2,543
-7,381
| -74% | -$4.25M | ﹤0.01% | 2386 |
|
|
2021
Q1 | $8.61M | Sell |
9,924
-646
| -6% | -$688K | ﹤0.01% | 1270 |
|
|
2020
Q4 | $9.8M | Sell |
10,570
-2,925
| -22% | -$3.07M | 0.01% | 1048 |
|
|
2020
Q3 | $13.9M | Sell |
13,495
-4,296
| -24% | -$4.62M | 0.01% | 823 |
|
|
2020
Q2 | $18M | Buy |
17,791
+11,454
| +181% | +$10.6M | 0.01% | 730 |
|
|
2020
Q1 | $5.5M | Buy |
6,337
+53
| +0.8% | +$52.7K | ﹤0.01% | 1204 |
|
|
2019
Q4 | $6.74M | Buy |
6,284
+491
| +8% | +$501K | ﹤0.01% | 1281 |
|
|
2019
Q3 | $5.35M | Sell |
5,793
-3,285
| -36% | -$3.61M | ﹤0.01% | 1364 |
|
|
2019
Q2 | $10.3M | Sell |
9,078
-2,025
| -18% | -$2.22M | 0.01% | 1359 |
|
|
2019
Q1 | $15.1M | Buy |
11,103
+2,168
| +24% | +$2.94M | 0.01% | 1128 |
|
|
2018
Q4 | $10.3M | Sell |
8,935
-12,688
| -59% | -$14.3M | 0.01% | 1285 |
|
|
2018
Q3 | $32.8M | Buy |
21,623
+4,923
| +29% | +$7.58M | 0.02% | 857 |
|
|
2018
Q2 | $26.1M | Sell |
16,700
-3,072
| -16% | -$4M | 0.01% | 1015 |
|
|
2018
Q1 | $22.8M | Buy |
19,772
+4,830
| +32% | +$6.36M | 0.01% | 1030 |
|
|
2017
Q4 | $17.7M | Buy |
14,942
+6,965
| +87% | +$8.73M | 0.01% | 1086 |
|
|
2017
Q3 | $10.7M | Buy |
7,977
+5,061
| +174% | +$5.33M | 0.01% | 1407 |
|
|
2017
Q2 | $2.35M | Sell |
2,916
-1,589
| -35% | -$1.11M | ﹤0.01% | 2450 |
|
|
2017
Q1 | $2.77M | Sell |
4,505
-2,019
| -31% | -$1.23M | ﹤0.01% | 2046 |
|
|
2016
Q4 | $3.49M | Buy |
6,524
+1,469
| +29% | +$733K | ﹤0.01% | 1896 |
|
|
2016
Q3 | $2.62M | Sell |
5,055
-3,008
| -37% | -$1.42M | ﹤0.01% | 2171 |
|
|
2016
Q2 | $3.31M | Buy |
8,063
+2,903
| +56% | +$1.33M | ﹤0.01% | 2053 |
|
|
2016
Q1 | $2.75M | Buy |
5,160
+238
| +5% | +$119K | ﹤0.01% | 2154 |
|
|
2015
Q4 | $3.75M | Buy |
4,922
+2,709
| +122% | +$1.8M | ﹤0.01% | 1999 |
|
|
2015
Q3 | $1.21M | Sell |
2,213
-75
| -3% | -$45.4K | ﹤0.01% | 2817 |
|
|
2015
Q2 | $1.34M | Buy |
2,288
+687
| +43% | +$400K | ﹤0.01% | 2772 |
|
|
2015
Q1 | $1.25M | Buy |
1,601
+1
| +0.1% | +$775 | ﹤0.01% | 2750 |
|
|
2014
Q4 | $1.09M | Buy |
+1,600
| New | +$1.03M | ﹤0.01% | 3145 |
|
Other funds holding KYNB
AC
6CM
GCP
Deutsche Bank's KYNB Position: Q2 2024 in Review
Deutsche Bank sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 1,616 shares — an estimated $94.9K sold.
Deutsche Bank first reported a position in KYNB in Q4 2014 and held it in 37 quarters. The position peaked at $32.8M in Q3 2018. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.
- Deutsche Bank reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
- Deutsche Bank sold 1,616 Kyntra Bio shares in Q2 2024, an estimated $94.9K.
- Deutsche Bank first reported a position in Kyntra Bio in Q4 2014 and held it in 37 quarters.
- Deutsche Bank's Kyntra Bio position peaked at $32.8M in Q3 2018.
- 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.
Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.